Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study. Frew JW, Navrazhina K, Sullivan-Whalen M, Gilleaudeau P, et al. Br J Dermatol 2021;184:350-352.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Frew JW, Navrazhina K, Sullivan-Whalen M, Gilleaudeau P, et al. Weekly administration of brodalumab in hidradenitis suppurativa: an open-label cohort study. Br J Dermatol 2021;184:350-352.
PMID: 32974912